Home » Report: Better Coordination, Planning Needed for US FDA’s Overseas Offices
Report: Better Coordination, Planning Needed for US FDA’s Overseas Offices
November 5, 2010
Better coordination between the U.S. Food and Drug Administration’s (FDA) overseas offices and their domestic counterparts, as well as long-term strategic planning, is needed to improve the role of those offices in the face of growing regulatory challenges, the U.S. Government Accountability Office (GAO) reports.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor